GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codexis Inc (LTS:0I0X) » Definitions » Ending Cash Position

Codexis (LTS:0I0X) Ending Cash Position : $59.63 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Codexis Ending Cash Position?

Codexis's Ending Cash Position for the quarter that ended in Mar. 2024 was $59.63 Mil.

Codexis's quarterly Ending Cash Position declined from Sep. 2023 ($76.63 Mil) to Dec. 2023 ($66.70 Mil) and declined from Dec. 2023 ($66.70 Mil) to Mar. 2024 ($59.63 Mil).

Codexis's annual Ending Cash Position declined from Dec. 2021 ($118.90 Mil) to Dec. 2022 ($116.03 Mil) and declined from Dec. 2022 ($116.03 Mil) to Dec. 2023 ($66.70 Mil).


Codexis Ending Cash Position Historical Data

The historical data trend for Codexis's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codexis Ending Cash Position Chart

Codexis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 92.22 150.82 118.90 116.03 66.70

Codexis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 104.88 94.15 76.63 66.70 59.63

Codexis Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Codexis's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=116.026+-49.329
=66.70

Codexis's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=66.697+-7.071
=59.63


Codexis Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Codexis's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Codexis (LTS:0I0X) Business Description

Traded in Other Exchanges
Address
200 Penobscot Drive, Redwood, CA, USA, 94063
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment. Geographically, it derives a majority of revenue from the APAC.

Codexis (LTS:0I0X) Headlines

No Headlines